{"transactions":[{"id":3096597,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":148173,"kind":"person","name":"Cranston Lynda Sarah","position":1,"cik":"0001633660","reported_name":"Cranston Lynda Sarah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2020-06-30T16:16:19.000Z","date":"2020-06-26","kind":"grant","acquired":true,"shares":39567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On September 5, 2019, the reporting person received options to purchase 39,567 shares which were subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the 2020 Annual Meeting of Stockholders. Stockholder approval of the increase was obtained on June 26, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest in twelve (12) equal monthly installments beginning on October 5, 2019."}],"balance_after":75000,"derivative":{"exercise_price":0.61,"expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":39567},"source":{"system":"sec-edgar","filing":"0001213900-20-016317","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1633660/000121390020016317/ownership.xml","form_type":"4"}},{"id":3096596,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":148173,"kind":"person","name":"Cranston Lynda Sarah","position":1,"cik":"0001633660","reported_name":"Cranston Lynda Sarah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-30T16:16:19.000Z","date":"2020-06-30","kind":"other","acquired":false,"shares":8,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by J.G. Cranston & Associates, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":332,"source":{"system":"sec-edgar","filing":"0001213900-20-016317","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633660/000121390020016317/ownership.xml","form_type":"4"}},{"id":3190882,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":148173,"kind":"person","name":"Cranston Lynda Sarah","position":1,"cik":"0001633660","reported_name":"Cranston Lynda Sarah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-31T16:16:57.000Z","date":"2020-03-31","kind":"other","acquired":false,"shares":8,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by J.G. Cranston & Associates, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":324,"source":{"system":"sec-edgar","filing":"0001213900-20-008217","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633660/000121390020008217/ownership.xml","form_type":"4"}},{"id":3327160,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":148173,"kind":"person","name":"Cranston Lynda Sarah","position":1,"cik":"0001633660","reported_name":"Cranston Lynda Sarah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-02T16:15:12.000Z","date":"2019-12-31","kind":"other","acquired":true,"shares":8,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by J.G. Cranston & Associates, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":316,"source":{"system":"sec-edgar","filing":"0000905718-20-000016","document":"delmarph_fm4dec312019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633660/000090571820000016/delmarph_fm4dec312019.xml","form_type":"4"}},{"id":3403167,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":148173,"kind":"person","name":"Cranston Lynda Sarah","position":1,"cik":"0001633660","reported_name":"Cranston Lynda Sarah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-01T16:22:54.000Z","date":"2019-09-30","kind":"other","acquired":true,"shares":8,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by J.G. Cranston & Associates, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":308,"source":{"system":"sec-edgar","filing":"0000905718-19-000815","document":"delmarph_fm4sept302019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633660/000090571819000815/delmarph_fm4sept302019.xml","form_type":"4"}},{"id":3419597,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":148173,"kind":"person","name":"Cranston Lynda Sarah","position":1,"cik":"0001633660","reported_name":"Cranston Lynda Sarah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2019-09-09T16:36:27.000Z","date":"2019-09-05","kind":"grant","acquired":true,"shares":35433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in twelve (12) equal monthly installments beginning on October 5, 2019."}],"balance_after":35433,"derivative":{"exercise_price":0.61,"expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":35433},"source":{"system":"sec-edgar","filing":"0000905718-19-000761","document":"delmarph_fm4sept52019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1633660/000090571819000761/delmarph_fm4sept52019.xml","form_type":"4"}},{"id":3419596,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":148173,"kind":"person","name":"Cranston Lynda Sarah","position":1,"cik":"0001633660","reported_name":"Cranston Lynda Sarah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2019-09-09T16:36:27.000Z","date":"2019-09-05","kind":"grant","acquired":true,"shares":39567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the next annual meeting, the shares subject to the option vest in twelve (12) equal monthly installments beginning on October 5, 2019."}],"balance_after":39567,"derivative":{"exercise_price":0.61,"expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":39567},"source":{"system":"sec-edgar","filing":"0000905718-19-000761","document":"delmarph_fm4sept52019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633660/000090571819000761/delmarph_fm4sept52019.xml","form_type":"4"}},{"id":3474740,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":148173,"kind":"person","name":"Cranston Lynda Sarah","position":1,"cik":"0001633660","reported_name":"Cranston Lynda Sarah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-01T16:20:26.000Z","date":"2019-06-28","kind":"other","acquired":true,"shares":8,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by J.G. Cranston & Associates, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On May 8, 2019, the issuer effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":300,"source":{"system":"sec-edgar","filing":"0001213900-19-011880","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633660/000121390019011880/ownership.xml","form_type":"4"}},{"id":3544384,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":148173,"kind":"person","name":"Cranston Lynda Sarah","position":1,"cik":"0001633660","reported_name":"Cranston Lynda Sarah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Performance Stock Units","published_at":"2019-05-01T18:29:49.000Z","date":"2019-04-30","kind":"disposition_to_issuer","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit represents the right to receive one share of common stock, to vest upon achievement of specified targets related to the Company's financial performance. Such performance stock units were unvested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each performance stock unit represents the right to receive one share of common stock, to vest upon achievement of specified targets related to the Company's financial performance. Such performance stock units were unvested."}],"balance_after":0,"derivative":{"expiration_date":"2022-07-07","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-19-007624","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633660/000121390019007624/ownership.xml","form_type":"4"}},{"id":3572021,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":148173,"kind":"person","name":"Cranston Lynda Sarah","position":1,"cik":"0001633660","reported_name":"Cranston Lynda Sarah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-01T16:37:28.000Z","date":"2019-03-29","kind":"other","acquired":true,"shares":71,"price":0.49,"value":34.79,"ownership":{"direct":false,"nature":"Held by J.G. Cranston & Associates, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":2912,"source":{"system":"sec-edgar","filing":"0001213900-19-005503","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633660/000121390019005503/ownership.xml","form_type":"4"}},{"id":3713353,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":148173,"kind":"person","name":"Cranston Lynda Sarah","position":1,"cik":"0001633660","reported_name":"Cranston Lynda Sarah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-02T18:19:03.000Z","date":"2018-12-31","kind":"other","acquired":true,"shares":71,"price":0.3419,"value":24.2749,"ownership":{"direct":false,"nature":"Held by J.G. Cranston & Associates, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":2841,"source":{"system":"sec-edgar","filing":"0001213900-19-000053","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633660/000121390019000053/ownership.xml","form_type":"4"}},{"id":3766956,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":148173,"kind":"person","name":"Cranston Lynda Sarah","position":1,"cik":"0001633660","reported_name":"Cranston Lynda Sarah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2018-11-13T16:40:12.000Z","date":"2018-11-08","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in twelve (12) equal monthly installments beginning on December 8, 2018."}],"balance_after":40000,"derivative":{"exercise_price":0.6099,"expiration_date":"2028-11-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001213900-18-015518","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633660/000121390018015518/ownership.xml","form_type":"4"}},{"id":3804363,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":148173,"kind":"person","name":"Cranston Lynda Sarah","position":1,"cik":"0001633660","reported_name":"Cranston Lynda Sarah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-01T16:07:47.000Z","date":"2018-09-28","kind":"other","acquired":true,"shares":71,"price":3.2,"value":227.2,"ownership":{"direct":false,"nature":"Held by J.G. Cranston & Associates, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":2770,"source":{"system":"sec-edgar","filing":"0001213900-18-013296","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633660/000121390018013296/ownership.xml","form_type":"4"}},{"id":3875245,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":148173,"kind":"person","name":"Cranston Lynda Sarah","position":1,"cik":"0001633660","reported_name":"Cranston Lynda Sarah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-03T16:40:51.000Z","date":"2018-06-29","kind":"other","acquired":true,"shares":71,"price":3.2,"value":227.2,"ownership":{"direct":false,"nature":"Held by J.G. Cranston & Associates, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":2699,"source":{"system":"sec-edgar","filing":"0001213900-18-008712","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633660/000121390018008712/ownership.xml","form_type":"4"}},{"id":3973231,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":148173,"kind":"person","name":"Cranston Lynda Sarah","position":1,"cik":"0001633660","reported_name":"Cranston Lynda Sarah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-03T16:05:54.000Z","date":"2018-03-30","kind":"other","acquired":true,"shares":71,"price":3.2,"value":227.2,"ownership":{"direct":false,"nature":"by J.G. Cranston & Associates, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock"}],"balance_after":2628,"source":{"system":"sec-edgar","filing":"0001213900-18-003986","document":"f4033018cranston_delmar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633660/000121390018003986/f4033018cranston_delmar.xml","form_type":"4"}},{"id":4112303,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":148173,"kind":"person","name":"Cranston Lynda Sarah","position":1,"cik":"0001633660","reported_name":"Cranston Lynda Sarah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-03T16:57:05.000Z","date":"2017-12-31","kind":"other","acquired":true,"shares":71,"price":3.2,"value":227.2,"ownership":{"direct":false,"nature":"by J.G. Cranston & Associates, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":2557,"source":{"system":"sec-edgar","filing":"0000905718-18-000013","document":"cranston_form4dec312017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633660/000090571818000013/cranston_form4dec312017.xml","form_type":"4"}},{"id":4197802,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":148173,"kind":"person","name":"Cranston Lynda Sarah","position":1,"cik":"0001633660","reported_name":"Cranston Lynda Sarah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-02T19:52:38.000Z","date":"2017-09-29","kind":"other","acquired":true,"shares":71,"price":3.2,"value":227.2,"ownership":{"direct":false,"nature":"Note"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by J.G. Cranston & Associates, Inc."}],"balance_after":2486,"source":{"system":"sec-edgar","filing":"0001213900-17-010210","document":"f4092917cranston_delmarpharm.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633660/000121390017010210/f4092917cranston_delmarpharm.xml","form_type":"4"}},{"id":4259089,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":148173,"kind":"person","name":"Cranston Lynda Sarah","position":1,"cik":"0001633660","reported_name":"Cranston Lynda Sarah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Performance Stock Units","published_at":"2017-07-11T21:34:13.000Z","date":"2017-07-07","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Subject to stockholder approval of the Company's 2017 Omnibus Equity Incentive Plan at the Company's annual meeting, each performance stock unit represents the right to receive one share of common stock upon vesting of the unit based on achievement of specified targets related to the Company's financial performance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to stockholder approval of the Company's 2017 Omnibus Equity Incentive Plan at the Company's annual meeting, each performance stock unit represents the right to receive one share of common stock upon vesting of the unit based on achievement of specified targets related to the Company's financial performance."}],"balance_after":200000,"derivative":{"expiration_date":"2022-07-07","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-17-007476","document":"f4070717cranston_delmarpharm.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1633660/000121390017007476/f4070717cranston_delmarpharm.xml","form_type":"4"}},{"id":4259088,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":148173,"kind":"person","name":"Cranston Lynda Sarah","position":1,"cik":"0001633660","reported_name":"Cranston Lynda Sarah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2017-07-11T21:34:13.000Z","date":"2017-07-07","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"12,000 options vest on June 30, 2018, and 3,000 options vest each three months thereafter starting September 30, 2018."}],"balance_after":36000,"derivative":{"exercise_price":2.11,"exercise_date":"2020-06-30","expiration_date":"2027-07-07","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001213900-17-007476","document":"f4070717cranston_delmarpharm.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633660/000121390017007476/f4070717cranston_delmarpharm.xml","form_type":"4"}},{"id":4264560,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":148173,"kind":"person","name":"Cranston Lynda Sarah","position":1,"cik":"0001633660","reported_name":"Cranston Lynda Sarah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-05T14:27:10.000Z","date":"2017-06-30","kind":"other","acquired":true,"shares":71,"price":3.2,"value":227.2,"ownership":{"direct":false,"nature":"Note"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by J.G. Cranston & Associates, Inc."}],"balance_after":2415,"source":{"system":"sec-edgar","filing":"0001213900-17-007145","document":"f4063017cranston_delmar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633660/000121390017007145/f4063017cranston_delmar.xml","form_type":"4"}},{"id":4271135,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":148173,"kind":"person","name":"Cranston Lynda Sarah","position":1,"cik":"0001633660","reported_name":"Cranston Lynda Sarah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-28T11:31:49.000Z","date":"2017-06-26","kind":"purchase","acquired":true,"shares":2083,"price":3.6,"value":7498.8,"ownership":{"direct":false,"nature":"Note"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person purchased the shares in a private transaction for an aggregate purchase price of CDN $10,000. Reported price is based on exchange rate of 0.75."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by J.G. Cranston & Associates, Inc."}],"balance_after":2344,"source":{"system":"sec-edgar","filing":"0001213900-17-006882","document":"f4062617cranston_delmarpha.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633660/000121390017006882/f4062617cranston_delmarpha.xml","form_type":"4"}},{"id":4365236,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":148173,"kind":"person","name":"Cranston Lynda Sarah","position":1,"cik":"0001633660","reported_name":"Cranston Lynda Sarah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-03T18:14:42.000Z","date":"2017-03-31","kind":"other","acquired":true,"shares":71,"price":3.2,"value":227.2,"ownership":{"direct":false,"nature":"Note"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by J.G. Cranston & Associates, Inc."}],"balance_after":261,"source":{"system":"sec-edgar","filing":"0001213900-17-003268","document":"f4033117cranston_delmar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633660/000121390017003268/f4033117cranston_delmar.xml","form_type":"4"}},{"id":4507956,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":148173,"kind":"person","name":"Cranston Lynda Sarah","position":1,"cik":"0001633660","reported_name":"Cranston Lynda Sarah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-03T13:54:55.000Z","date":"2016-12-31","kind":"other","acquired":true,"shares":71,"price":3.2,"value":227.2,"ownership":{"direct":false,"nature":"Note"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by J.G. Cranston & Associates, Inc."}],"balance_after":190,"source":{"system":"sec-edgar","filing":"0001213900-17-000022","document":"f4123116cranston_delmar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633660/000121390017000022/f4123116cranston_delmar.xml","form_type":"4"}},{"id":4584433,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":148173,"kind":"person","name":"Cranston Lynda Sarah","position":1,"cik":"0001633660","reported_name":"Cranston Lynda Sarah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-05T13:57:13.000Z","date":"2016-10-03","kind":"other","acquired":true,"shares":71,"price":3.2,"value":227.2,"ownership":{"direct":false,"nature":"Note"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Share are held by J.G. Cranston & Associates, Inc."}],"balance_after":119,"source":{"system":"sec-edgar","filing":"0001213900-16-017304","document":"f4100316cranston_delmar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633660/000121390016017304/f4100316cranston_delmar.xml","form_type":"4"}}]}